Cutler Group LP Genetic Technologies LTD Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 18, 2022	SELL	$0.0 - $0.01 $0 - $4	-400 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$0.0 - $0.01 $0 - $2	-200 Reduced 33.33%	400 $0
Q2 2021 Jul 19, 2021	SELL	$0.0 - $0.02 $0 - $130	-6,500 Reduced 91.55%	600 $0
Q1 2021 Apr 26, 2021	BUY	$0.0 - $0.01 $0 - $67	6,700 Added 1675.0%	7,100 $2,000
Q4 2020 Jan 21, 2021	BUY	$0.0 - $0.0 $0 - $0	100 Added 33.33%	400 $0

Q3 2020 Oct 27, 2020	BUY	$0.0 - $0.0 $0 - $0	300 New	300 $0

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $13.2M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.